uniQure N.V. Shares Issued, Price Per Share
uniQure N.V. (QURE) had Shares Issued, Price Per Share of $17.00 per share as of 2025-01-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Equity
us-gaap:SharesIssuedPricePerShare · last filed 2026-03-02
- 2025-01-31: Shares Issued, Price Per Share $17.00.
- 2019-09-13: Shares Issued, Price Per Share $46.00.
- 2019-09-10: Shares Issued, Price Per Share $46.00.
- 2018-05-07: Shares Issued, Price Per Share $28.50.
| Period end | Shares Issued, Price Per Share |
|---|---|
| 2025-01-31 | $17.00 10-K · filed 2026-03-02 |
| 2019-09-13 | $46.00 10-K · filed 2022-02-25 |
| 2019-09-10 | $46.00 10-K · filed 2022-02-25 |
| 2018-05-07 | $28.50 10-K · filed 2021-03-01 |
| 2017-10-27 | $18.25 10-K · filed 2020-03-02 |
| 2015-04-15 | $29.50 10-K · filed 2018-03-14 |
| 2014-02-05 | $17.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |